The Health Pod, Baker McKenzie’s industry podcast series, highlights sector-specific issues and trends that affect healthcare and life sciences companies.
Episode 7: The ins and outs of handling material non-public information
Healthcare and life sciences are among the most heavily regulated industries, and the US Securities and Exchange Commission continues to focus on healthcare and life sciences companies when it comes to disclosure and reporting requirements. If not managed carefully, the treatment and misuse of material non-public information can expose firms to significant liability and reputational risks. In this episode of The Health Pod, Amy Greer and Carol Stubblefield join David Wardell to discuss best practices when managing material non-public information including determinations of materiality, disclosure obligations, insider trading policies and 10b5-1 plans.
Episode 1 Canada: Health Canada and the FDA’s response to COVID-19 (Podcast)
Episode 2 EU and Mexico: COVID-19 Impact on biopharma clinical development in the EU and Mexico (Podcast)
Episode 3 International: Alternative arrangements for biopharma clinical funding (Podcast)
Episode 4 Europe: UK and EU Competition law in times of COVID-19 and beyond (Podcast)
Episode 5 Japan: Pharmaceuticals market – Distinguishing features and industry practice (Podcast)
Episode 6 Japan: Pharmaceuticals market – Regulatory landscape (Podcast)